-
Comparison of the use of internal limiting membrane flaps versus conventional ILM peeling on post-operative anatomical and visual outcomes in large macular holes Eye (IF 3.9) Pub Date : 2024-03-16 George Riding, Boon Lin Teh, David Yorston, David H. Steel
Background Idiopathic full-thickness macular hole (iFTMH) closure rates following conventional vitrectomy, gas tamponade and internal limiting membrane (ILM) peeling decrease when the minimum linear diameter (MLD) ≥ 500 microns. ILM flap creation has been proposed to improve closure in larger holes. This study evaluated the anatomical and functional impact of ILM flap introduction to routine practice
-
Global Ophthalmology in the Middle East: a Task Force proposal Eye (IF 3.9) Pub Date : 2024-03-14 Mattan Arazi, Sila Bal, Joshua R. Ehrlich, Jacquelyn O’Banion, Fatma Shakarchi
The field of Global Ophthalmology is an evolving and rapidly expanding movement, as the global demand to address eyecare equity and preventable causes of vision impairment continues to grow [1, 2]. Globalization, while beneficial in many regards, has brought with it unique challenges to eyecare. Many of these challenges have been addressed through efforts such as capacity building, telemedicine, humanitarian
-
Visual outcomes and complications of combined versus sequential pars plana vitrectomy and phacoemulsification for epiretinal membrane Eye (IF 3.9) Pub Date : 2024-03-14 Yousef A. Fouad, Mohamed K. Soliman, Abdelrahman M. Elhusseiny, Yit C. Yang, Ahmed B. Sallam
-
Head to head comparison of diagnostic performance of three non-mydriatic cameras for diabetic retinopathy screening with artificial intelligence Eye (IF 3.9) Pub Date : 2024-03-11 Mehmet Erkan Doğan, Ahmet Burak Bilgin, Ramazan Sari, Mehmet Bulut, Yusuf Akar, Mustafa Aydemir
-
Variation in eye care professional distribution across Europe, a survey Eye (IF 3.9) Pub Date : 2024-03-12 Louis Arnould, Balazs Varsanyi, Edward Dervan, Chiara Posarelli, Helena Prior Filipe, Tristan Bourcier, Andreas Wedrich, Renata Ivekovic, Goran Petrovski, Giorgio L. Porro, Guna Laganovska, Vilma Jurate Balciuniene, Ewa Mrukwa-Kominek, Karsten Paust, Segolene Roemer, Ivan O. Haefliger, Huban Atilla, Paul Ursell, Barba Cvenkel, Jens Kiilgaard, Christina Grupcheva, Alena Furdova, Marnix Claeys, Klara
Eye care professionals across Europe encompass a range of professionals who screen, diagnose and treat ocular diseases. Their qualifications and roles might differ notably based on national regulations, healthcare system and number of ophthalmologists per inhabitants. There is little objective data presenting how the spectrum of eye care professionals differs between countries in Europe, and how their
-
Orbital CT scan parameters in dysthyroid optic neuropathy: a systematic review and meta-analysis Eye (IF 3.9) Pub Date : 2024-03-12 Thansit Srisombut, Niracha Arjkongharn, Nattaporn Vongsa, Arparat Kanacharoen, Parinee Kemchoknatee
-
Ultrawide-field fluorescein angiography features in patients with anterior uveitis Eye (IF 3.9) Pub Date : 2024-03-12 Nam V. Nguyen, Enny Oyeniran, Alexander Zeleny, Michelle Chen, Noha A. Sherif, Eleni Konstantinou, Susan Vitale, H. Nida Sen, Shilpa Kodati
-
Qualitative and quantitative comparisons of type 1 macular neovascularizations between pachychoroid neovasculopathy and neovascular age-related macular degeneration using optical coherence tomography angiography Eye (IF 3.9) Pub Date : 2024-03-12 Özge Yanık, Sibel Demirel, Gökçen Özcan, Figen Batıoğlu, Emin Özmert
-
Systematic review of clinical practice guidelines for the diagnosis and management of retinal vein occlusion Eye (IF 3.9) Pub Date : 2024-03-11 Jose Galvez-Olortegui, Rachid Bouchikh-El Jarroudi, Isabel Silva-Ocas, Hector Palacios-Herrera, Marta Cubillas-Martin, Miguel Zavaleta-Mercado, Carmen Burgueño-Montañes, Tomas Galvez-Olortegui
Background/objectives To assess the methodological quality of Clinical Practice Guidelines (CPG) for the diagnosis and management of Retinal Vein Occlusion (RVO). Methods A systematic review of CPGs for the diagnosis and management of RVO was carried out with a search in databases, metasearch engines, CPG development institutions, ophthalmology associations and CPG repositories until April 2022. Search
-
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 Eye (IF 3.9) Pub Date : 2024-03-09 Konrad Pesudovs, Van Charles Lansingh, John H. Kempen, Ian Tapply, Arthur G. Fernandes, Maria V. Cicinelli, Alessandro Arrigo, Nicolas Leveziel, Paul Svitil Briant, Theo Vos, Serge Resnikoff, Hugh R. Taylor, Tabassom Sedighi, Seth Flaxman, Jaimie Steinmetz, Rupert Bourne
-
Corneal topography image of bilateral superior pellucid marginal degeneration Eye (IF 3.9) Pub Date : 2024-03-07 Vishal M. Thakkar
-
Lord of the Ring technique for capsular tension ring in subluxated cataract surgery Eye (IF 3.9) Pub Date : 2024-03-07 Pei-Chang Wu
-
The Royal College of Ophthalmologists’ National ophthalmology database study of cataract surgery: Report 14, cohort analysis – the impact of CapsuleGuard® utilisation on cataract surgery posterior capsule rupture rates Eye (IF 3.9) Pub Date : 2024-03-07 John C. Buchan, Charlotte F. E. Norridge, Beth Barnes, Martina Olaitan, Paul H. J. Donachie
-
Comparison of intraocular pressure profiles during the water drinking test and the modified diurnal tension curve Eye (IF 3.9) Pub Date : 2024-03-07 Timothy E. Yap, Yuan Gao, Hanif Ahmad, Fernanda Susanna, Remo Susanna, Eduardo M. Normando, Philip A. Bloom, Maria Francesca Cordeiro
-
Systematic hydroxychloroquine retinopathy monitoring programme: cost benefit comparing to a hospital-based system Eye (IF 3.9) Pub Date : 2024-03-05 S. P. Meredith, S. Palmer, H. Beharrell, S. Coe, H. Hobbs, P. Kirby
Guidance on hydroxychloroquine (HCQ) retinopathy monitoring was published by the Royal College of Ophthalmologists in 2018 [1]. It is possible to detect, while asymptomatic, the development of retinopathy therefore informing joint decisions regarding the repeat HCQ prescription. The British Ophthalmological Surveillance Unit published in Eye 24 new cases of HCQ retinopathy reported by ophthalmologists
-
The use of anti-VEGF agents in pregnancy Eye (IF 3.9) Pub Date : 2024-03-04 Kevin Gallagher, Ffion Brown, Ahmed Bilal, Ahmed Al-Janabi, Nigel Davies
The use of anti-vascular endothelial growth factor (VEGF) agents in pregnancy is a concern. VEGF plays an important role in embryogenesis [1,2,3], has an essential role in normal pregnancy (e.g. implantation/placentation) and has been implicated in several obstetric complications (pre-eclampsia, miscarriage, intrauterine growth restriction, preterm delivery) [4, 5]. Drug manufacturer and regulator
-
Real-world effects of anti-vascular endothelial growth factor injection frequency on visual outcomes in patients with diabetic macular oedema Eye (IF 3.9) Pub Date : 2024-03-06 Carter J. Payne, Urvi Gupta, Christopher M. Maatouk, Blanche L. Kuo, Scott W. Perkins, Rishi P. Singh, Katherine E. Talcott
-
Unilateral visual impairment and blindness in school children – prevalence and aetiology in Saki-East LGA of Oyo State, Nigeria Eye (IF 3.9) Pub Date : 2024-03-06 Folahan Adesola Ibukun, Mary Ogbenyi Ugalahi, Charles Obu Bekibele
Objective This study determined the prevalence and aetiology of unilateral visual impairment (VI) and blindness and its associated factors in school children. Methods We conducted a multistage, cross-sectional study in primary and secondary schools of Saki-East Local Government Area of Oyo State, Nigeria. Unilateral VI was defined as presenting visual acuity (PVA) worse than +0.3 LogMAR (6/12) and
-
Disease latency bias and the protective effect of metformin against age-related macular degeneration Eye (IF 3.9) Pub Date : 2024-03-05 Jennifer Y. M. Ling, Mohammad A. Mansournia, Mahyar Etminan
-
Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs Eye (IF 3.9) Pub Date : 2024-03-04 Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Bandello, Anat Loewenstein, Baruch D. Kuppermann
India was the first country in the world to approve ranibizumab biosimilar. The Drug Controller General of India (DCGI) approved Razumab (Intas Pharmaceuticals Limited, Ahmedabad, India) in 2015 as the first biosimilar ranibizumab [1]. The innovator ranibizumab molecule (Lucentis, Genentech, USA) patent expired in June 2020 (USA) and July 2022 (EU) [2]. This has led to a flurry of new drug applications
-
Effective refractive error coverage and spectacle coverage among school children in Telangana, South India Eye (IF 3.9) Pub Date : 2024-03-04 Winston D Prakash, Srinivas Marmamula, Jill Keeffe, Rohit C. Khanna
-
Imaging of aqueous outflow in health and glaucoma. Justifying the re-direction of aqueous Eye (IF 3.9) Pub Date : 2024-03-01 Jed A. Lusthaus
-
Expectation of tele-ophthalmology in remote areas including islands Eye (IF 3.9) Pub Date : 2024-02-28 Kazuhiko Kotani
We read with great interest the Joseph study that reported an acceptable model of tele-ophthalmology for major eye diseases among rural people, in comparison to in-person examinations by a specialist ophthalmologist [1]. As stated by Joseph [1], although tele-ophthalmology has been suggested as a new and good solution for delivering eye care in rural and remote areas, the suggestion is based on prior
-
Comparison of the long-term effects of atropine in combination with Orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents Eye (IF 3.9) Pub Date : 2024-02-28 Tao Tang, Yuchang Lu, Xuewei Li, Heng Zhao, Kai Wang, Yan Li, Mingwei Zhao
-
A comparison of keratoconus progression following collagen cross-linkage using standard or personalised keratometry thresholds Eye (IF 3.9) Pub Date : 2024-02-26 Ji-Peng Olivia Li, Howard P. Maile, Catey Bunce, Lynn Kandakji, Marcello T. Leucci, Bruce D. Allan, Stephen J. Tuft, Nikolas Pontikos, Daniel M. Gore
-
Corneal stress‒strain index in relation to retinal nerve fibre layer thickness among healthy young adults Eye (IF 3.9) Pub Date : 2024-02-24 Min-Xin Liu, Dan-Lin Li, Zhi-Jian Yin, Yue-Zu Li, Ya-Jie Zheng, Yu Qin, Rong Ma, Gang Liang, Chen-Wei Pan
-
Macula vs periphery in diabetic retinopathy: OCT-angiography and ultrawide field fluorescein angiography imaging of retinal non perfusion Eye (IF 3.9) Pub Date : 2024-02-24 Stela Vujosevic, Francesca Fantaguzzi, Paolo S. Silva, Recivall Salongcay, Marco Brambilla, Emanuele Torti, Paolo Nucci, Tunde Peto
-
The neurovascular retinal involvement in a large population of patients recovered from COVID-19: an OCT and OCT angiography study Eye (IF 3.9) Pub Date : 2024-02-24 Eleonora Cosmo, Luisa Frizziero, Stefano Schiavon, Anna Maria Cattelan, Davide Leoni, Alfio Capizzi, Tommaso Torresin, Giulia Midena, Edoardo Armato Smaniotto Dai Roveri, Raffaele Parrozzani, Edoardo Midena
Background This study aimed to assess the neuronal and microvascular retinal and choroidal involvement in COVID-19 recovered patients using optical coherence tomography (OCT) and OCT angiography (OCTA). Methods This observational cross-sectional study recruited patients recovered from COVID-19 and a group of healthy controls for comparisons. OCT (peripapillary scan and macular map) and OCTA (macular
-
Infographic: study design of the BALATON and COMINO phase 3 randomised trials of faricimab in patients with retinal vein occlusion Eye (IF 3.9) Pub Date : 2024-02-23 Andrew Chang, Aachal Kotecha, Faiz Kermani, Insaf Saffar
-
Infographic: Ranibizumab for macular edema following central retinal vein occlusion (CRUISE) Eye (IF 3.9) Pub Date : 2024-02-23 Robyn Gayle K. Dychiao, Kei Gabrielle R. Crisostomo, David Marco M. Magpantay, Corrina P. Azarcon, Jose Carlo M. Artiaga
-
Deprivation and the location of primary care optometry services in Scotland Eye (IF 3.9) Pub Date : 2024-02-23 Anna Blake, Jonathan Nairn, Toby Boote, Cara Owens, Benjamin Forrest, David Lockington
-
Structural control of corneal transparency, refractive power and dynamics Eye (IF 3.9) Pub Date : 2024-02-23 Keith M. Meek, Carlo Knupp, Philip N. Lewis, Siân R. Morgan, Sally Hayes
-
Scleral sutured aniridia intraocular lens (Morcher®): indications and long-term outcomes Eye (IF 3.9) Pub Date : 2024-02-23 Rabia Bourkiza, Georgios Vakros, Sonali Tarafdar, Elizabeth Yang, David G. Charteris
-
Robotic assisted orbital surgery for resection of advanced periocular tumours – a case series report on the feasibility, safety and outcome Eye (IF 3.9) Pub Date : 2024-02-22 Mohsan Malik, Claire Daniel, Jack Faulkner, Jimmy Uddin, Asit Arora, Jean-Pierre Jeannon
-
Expanded field: filling the gap between macula and widefield Eye (IF 3.9) Pub Date : 2024-02-21 Francesco Romano, Xinyi Ding, John B. Miller
-
Effect of adalimumab on choroidal thickness and choroidal vascularity index in eyes with non-infectious uveitis using enhanced-depth imaging optical coherence tomography Eye (IF 3.9) Pub Date : 2024-02-20 Cem Evereklioglu, Elif Er Arslantas, Hidayet Sener, Zeynep Akkul, Kamran Gahramanov, Duygu Gulmez Sevim, Osman Ahmet Polat, Fatih Horozoglu
-
Prevalence and risk factors for impaired activities of daily living in patients with neo-vascular age-related macular degeneration who present for anti-VEGF treatment Eye (IF 3.9) Pub Date : 2024-02-19 Kim Van Vu, Paul Mitchell, Harshil Dharamdasani Detaram, George Burlutsky, Gerald Liew, Bamini Gopinath
Background/Objectives To assess the prevalence and correlates of impaired activities of daily living (ADLs) in patients with neovascular age-related macular degeneration (nAMD) who present for anti-vascular endothelial growth factor (VEGF) therapy. Methods In a clinic-based cohort of 437 patients with nAMD who presented for anti-VEGF therapy, the Older American Resources and Services Scale (OARS) was
-
Principles of microscopy for ophthalmologists Eye (IF 3.9) Pub Date : 2024-02-19 William Bradshaw Amos
-
The changing landscape of thyroid eye disease: current clinical advances and future outlook Eye (IF 3.9) Pub Date : 2024-02-19 Malik Moledina, Erika M. Damato, Vickie Lee
-
Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc Eye (IF 3.9) Pub Date : 2024-02-14 Ari Leshno, Nikhil Bommakanti, Carlos Gustavo De Moraes, Mae O. Gordon, Michael A. Kass, George A. Cioffi, Jeffrey M. Liebmann
-
Amniotic membrane graft in the management of macular hole in high myopia Eye (IF 3.9) Pub Date : 2024-02-14 Sayena Jabbehdari, Pedro Tetelbom, Sami Uwaydat
-
Central serous chorioretinopathy with a golden sheen Eye (IF 3.9) Pub Date : 2024-02-14 Priyanka Sanghi, Emilia Bober, Omar A. Mahroo, Luke Nicholson
-
Google DeepMind’s gemini AI versus ChatGPT: a comparative analysis in ophthalmology Eye (IF 3.9) Pub Date : 2024-02-14 Mouayad Masalkhi, Joshua Ong, Ethan Waisberg, Andrew G. Lee
-
Glaucoma as a cause of optic nerve abnormalities on magnetic resonance imaging Eye (IF 3.9) Pub Date : 2024-02-14 Rasha Mosleh, Fernando Labella Álvarez, Walid Bouthour, Amit M. Saindane, Michael Dattilo, Beau B. Bruce, Nancy J. Newman, Valerie Biousse
-
Infectious eye disease in the 21st century—an overview Eye (IF 3.9) Pub Date : 2024-02-14 Gerry Clare, John H. Kempen, Carlos Pavésio
Infectious diseases affecting the eye often cause unilateral or asymmetric visual loss in children and people of working age. This group of conditions includes viral, bacterial, fungal and parasitic diseases, both common and rare presentations which, in aggregate, may account for a significant portion of the global visual burden. Diagnosis is frequently challenging even in specialist centres, and many
-
Ambient ultraviolet radiation and ocular melanoma incidence in the United States, 2000−2019 Eye (IF 3.9) Pub Date : 2024-02-13 Basilica M. Arockiaraj, Elizabeth K. Cahoon, Michael R. Sargen, Erping Long, Margaret A. Tucker, Jim Z. Mai
-
A novel integrated practice unit approach to peri-ocular skin cancer management Eye (IF 3.9) Pub Date : 2024-02-13 L. Y. Goh, C. Downie, A. M. S. Morley
-
A side-by-side evaluation of Llama 2 by meta with ChatGPT and its application in ophthalmology Eye (IF 3.9) Pub Date : 2024-02-12 Mouayad Masalkhi, Joshua Ong, Ethan Waisberg, Nasif Zaman, Prithul Sarker, Andrew G. Lee, Alireza Tavakkoli
-
Local anaesthesia under sedation versus general anaesthesia for brachytherapy-treated patients with uveal melanoma: A patient-reported outcome study Eye (IF 3.9) Pub Date : 2024-02-12 Max Davidson, Alastair Glossop, Hibba Quhill
In the United Kingdom, surgical procedures to treat uveal tumours are traditionally performed under general anaesthetic (GA), as there may be significant intraoperative manipulation of the globe and orbital structures [1]. Local anaesthetic (LA) alone is generally not appropriate, particularly with procedures such as insertion and removal of Ruthenium-106 (“plaque”) brachytherapy, which remains the
-
Economic evaluations in cataract surgery: a narrative review Eye (IF 3.9) Pub Date : 2024-02-12 José Ginel, N. Burguera, D. Piñero, A. Sáez-Martín, A. Haro De Rosario, J. Fernández
-
Impact of RB1 gene screening from blood collected on a single day from 411 family members of 113 Retinoblastoma survivors in India Eye (IF 3.9) Pub Date : 2024-02-10 Ayyasamy Vanniarajan, Puja Maitra, Karuvel Kannan Saraswathi, Parag K. Shah
-
Comment on: ‘Prevalence of co-existent neoplasia in clinically diagnosed pterygia in a UK population’ Eye (IF 3.9) Pub Date : 2024-02-10 Suraj Kumar Chaurasiya, Mahendra Singh, Piyush Kohli
We read with keen interest the recently published study titled “Prevalence of co-existent neoplasia in clinically diagnosed pterygia in a UK population” by Quhill et al. [1]. We wish to commend the authors for their invaluable contribution to the field of ophthalmology, particularly illuminating histopathological records to investigate the prevalence of ocular surface squamous neoplasia (OSSN) and
-
Oral fluorescein angiography in the diagnosis of paediatric optic nerve abnormalities Eye (IF 3.9) Pub Date : 2024-02-10 Robert Thomas Brady, Hrishikesh Kaza, Nikhil Jain, Brinda Muthusamy
-
Triangular pupil: the early sign of ICE syndrome Eye (IF 3.9) Pub Date : 2024-02-09 Fen Tang, Fan Xu
-
Multiplatform tear proteomic profiling reveals novel non-invasive biomarkers for diabetic retinopathy Eye (IF 3.9) Pub Date : 2024-02-09 Zixin Fan, Yarou Hu, Laijiao Chen, Xiaofeng Lu, Lei Zheng, Dahui Ma, Zhiqiang Li, Jingwen Zhong, Lin Lin, Sifan Zhang, Guoming Zhang
-
Comment on: ‘Silicone oil residual after vitrectomy for rhegmatogenous retinal detachment’ Eye (IF 3.9) Pub Date : 2024-02-07 Pradeep Kumar Panigrahi
We went through the article titled “Silicone oil residual after vitrectomy for rhegmatogenous retinal detachment” by Zhao et al. [1]. This is a well conducted study providing vitreo-retinal surgeons with a new insight regarding residual silicon oil following vitrectomy. We have a few queries for the authors. It is well known that silicon oil emulsification increases with increasing duration of silicon
-
Prophylaxis against intraocular pressure spikes following uncomplicated phacoemulsification: a systematic-review and meta-analysis Eye (IF 3.9) Pub Date : 2024-02-07 Raageen Kanjee, Marko M. Popovic, Ali Salimi, Cindy M. L. Hutnik, Iqbal Ike K. Ahmed, Hady Saheb
-
Sight impairment registration in Trinidad: trend in causes and population coverage in comparison to the National Eye Survey of Trinidad and Tobago Eye (IF 3.9) Pub Date : 2024-02-07 Shivaa Ramsewak, Frank Deomansingh, Blaine Winford, Debra Bartholomew, Vedatta Maharaj, Amandi Fraser, Deo Singh, Kenneth Suratt, Vrijesh Tripathi, Kevin McNally, Subash Sharma, Covadonga Bascaran, Samuel S. Ramsewak, Rupert R. A. Bourne, Tasanee Braithwaite
-
Response to ‘Comment on: ‘Silicone oil residual after vitrectomy for rhegmatogenous retinal detachment” Eye (IF 3.9) Pub Date : 2024-02-06 Chunhui Jiang, Hongmei Zhao, Tongjie Cheng
Thank you for the letter and questions by Dr Pradeep Kumar Panigrahi. For the first question, we did not focus on patients with emulsified silicone oil (SO) in the anterior chamber in this study. However, in another one of our studies [1], we investigated the characteristics of emulsified SO drops in the anterior part by ultrasound biomicroscopy (UBM) before SO removal in patients who underwent pars
-
Effects of brightness variations on a smartphone-based version of Radner reading charts Eye (IF 3.9) Pub Date : 2024-02-06 Paolo A. Grasso, Massimo Gurioli, Laura Boccardo